HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.

AbstractINTRODUCTION:
The efficacy of antithrombin (AT) supplementation against septic disseminated intravascular coagulation (DIC) may depend on various pre-existing factors, particularly the AT dose and multiple organ dysfunction severity. This study aimed to identify the impactful factors for early DIC recovery.
METHODS:
Patients' clinical records, including AT therapy and septic DIC data, were retrospectively extracted from January 2015 to December 2020. The patients were divided into those with early DIC recovery (n = 34) and those without (n = 37). Multivariate logistic regression analysis determined significant independent factors. Time-to-event analysis confirmed how these factors affected the DIC recovery time.
RESULTS:
The AT dose per patient body weight (odds ratio [95% confidence interval]: 2.879 [1.031-8.042], P = 0.044) and pre-existing organ dysfunction severity (0.333 [0.120-0.920], P = 0.034) were significant independent factors affecting early DIC recovery. A higher AT dose significantly shortened the DIC recovery time among patients with severe organ dysfunction (P < 0.01), but not among non-severe patients (P = 0.855).
CONCLUSION:
The therapeutic efficacy of AT treatment for septic DIC might depend on the severity of pre-existing organ failure and the AT dose per patient body weight.
AuthorsHiromitsu Kuroda, Hiroomi Tatsumi, Tomoko Sonoda, Yoshiki Masuda
JournalClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (Clin Appl Thromb Hemost) 2022 Jan-Dec Vol. 28 Pg. 10760296221080942 ISSN: 1938-2723 [Electronic] United States
PMID35187966 (Publication Type: Journal Article)
Chemical References
  • Antithrombins
Topics
  • APACHE
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antithrombins (administration & dosage, adverse effects, therapeutic use)
  • Body Weight
  • Comorbidity
  • Disseminated Intravascular Coagulation (drug therapy, epidemiology, etiology)
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multiple Organ Failure (epidemiology, etiology)
  • Organ Dysfunction Scores
  • Patient Acuity
  • Retrospective Studies
  • Sepsis (complications)
  • Sex Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: